StockWatch
·
Biotechnology: Pharmaceutical Preparations
AuditorJul 1, 2026, 07:16 AM

CorMedix Changes Auditor from CBIZ CPAs to Ernst & Young

AI Summary

CorMedix Inc. announced a change in its independent registered public accounting firm. On June 25, 2026, the company dismissed CBIZ CPAs P.C. and appointed Ernst & Young LLP (EY) for the fiscal year ending December 31, 2026. There were no disagreements with CBIZ CPAs on accounting principles, financial disclosure, or auditing scope, except for a previously disclosed material weakness in internal control over financial reporting related to non-routine transactions.

Key Highlights

  • CorMedix dismissed CBIZ CPAs P.C. as its independent registered public accounting firm on June 25, 2026.
  • Ernst & Young LLP (EY) was appointed as the new independent registered public accounting firm for 2026.
  • No disagreements with CBIZ CPAs on accounting principles or practices were reported.
  • A material weakness in internal control over financial reporting was previously reported for fiscal year 2025.
  • The material weakness related to timely review of significant, non-routine transactions.
  • No consultations with EY occurred regarding accounting matters prior to their appointment.
  • CBIZ CPAs' report for fiscal year 2025 did not contain adverse opinions or disclaimers.